...
首页> 外文期刊>Thoracic cancer. >Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database
【24h】

Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database

机译:通过监测,流行病学和最终结果数据库的恶性胸膜间皮瘤的外科患者胚胎患者的存活分析

获取原文

摘要

Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor that originates from the pleura and has a poor prognosis. Eligible patients can benefit from surgery, but their survival is affected by many factors. Therefore, we created a graphic model that could predict the prognosis of surgically treated patients. We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results database from 2004 to 2014 to identify the key factors affecting the prognosis of surgically treated MPM patients. On this basis we built a nomogram to predict survival. We then evaluated the performance of the nomogram in a validation cohort. In a training cohort of 828 cases, independent prognostic factors, including age, gender, histological type, differentiation, N stage, chemotherapy, type of surgery, and lymph node dissection, were identified. We then developed a nomogram to evaluate individual patient survival. In Kaplan-Meier analysis, a higher score in the nomogram was associated with a worse prognosis. We also used a validation cohort consisting of 312 patients to evaluate the performance of the nomogram, which was well calibrated and had good discrimination ability, with concordance indices of 0.715 and 0.656 for the training and validation cohorts, respectively. This study has improved our understanding of resected MPM and shown that key factors, including age and histological type, are associated with overall survival. The nomogram is a reliable tool that can help clinicians turn individualized prediction into reality and maximize patient benefit by identifying the most beneficial treatment approach. ? 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:恶性胸膜间皮瘤(MPM)是一种罕见而腐蚀性的肿瘤,源于胸膜,预后差。符合条件的患者可以从手术中受益,但他们的生存受到许多因素的影响。因此,我们创建了一种可以预测手术治疗患者的预后的图形模型。从2004年至2014年回顾性地分析了来自监测,流行病学和最终结果数据库的数据,以确定影响手术治疗的MPM患者预后的关键因素。在此基础上,我们建立了一个预测生存的罗维图。然后,我们在验证队列中评估了NOM图的性能。在828例患者的培训队列中,鉴定了独立的预后因素,包括年龄,性别,组织学型,分化,N阶段,化疗,手术类型,以及淋巴结解剖和淋巴结解剖。然后,我们开发了一个评估个人患者生存的载体。在KAPLAN-MEIER分析中,ROM图中得分更高的分数与更糟糕的预后相关。我们还使用了由312名患者组成的验证队列,以评估NOM图的性能,这些验证能力良好并具有良好的歧视能力,分别为培训和验证队列0.715和0.656的一致性指数。本研究提高了我们对切除的MPM的理解,并表明包括年龄和组织学类型,包括整体存活的关键因素。 NOM图是一种可靠的工具,可以帮助临床医生将个性化预测变为现实,并通过识别最有益的处理方法来最大化患者的利益。 ? 2019年的作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号